Previous 10 | Next 10 |
Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov...
ABIOMED, Inc. (ABMD) Q2 2019 Earnings Call November 01, 2018 8:00 am ET Executives Ingrid Goldberg - ABIOMED, Inc. Michael R. Minogue - ABIOMED, Inc. Todd A. Trapp - ABIOMED, Inc. Analysts Chris Pasquale - Guggenheim Securities LLC Jayson T. Bedford - Raymond James & ...
The following slide deck was published by ABIOMED, Inc. in conjunction with their 2018 Q2 earnings Read more ...
Abiomed (NASDAQ: ABMD ): Q2 Non-GAAP EPS of $0.81 beats by $0.08 ; GAAP EPS of $1.09 beats by $0.36 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
DANVERS, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quarter fiscal 2019 revenue of $181.8 million, an increase of 37% compared to revenue of $132.8 million for the ...
AAON , AAWW , ABMD , AGIO , ALE , AMAG , AMCX , AME , AMRN , ARES , AROC , ARW , AVP , AYR , BCE , BID , BLL , BMCH , BSIG , CBRE , CCOI , CEIX , CHD , CHSP , CI , CJ , CNQ , CNSL , CWT , D , DM , DNOW , DWDP , EEX , EGRX , EPAM , EXC , EXLS , FLWS , F...
ABIOMED ( ABMD -7.7% ) is down in early trade. Shares have lost 30% of their value since touching $459.75 on October 1. No particular news accounts for the action. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more ...
October is still only a little more than 15 trading days old, but there are already 31 stocks in the S&P 500 that are down over 15% on the month. The table below lists each of those 31 names, and while it's not uncommon to see volatile stocks from the Technology or Consumer Discretionary s...
NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of National Western Life Group, Inc. (NASDAQ:NWLI), Whitestone REIT (NYSE...
DANVERS, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, November 1, 2018, the Company will release financial results for the second quarter of fiscal 2019. The Company will host a conference call to discuss the results on Thursday, Novemb...
News, Short Squeeze, Breakout and More Instantly...
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...